이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
TransMedics Group 관리
관리 기준 확인 4/4
TransMedics Group's CEO는 Waleed Hassanein, Aug1998 에 임명되었습니다 의 임기는 26.08 년입니다. 총 연간 보상은 $ 6.76M, 9.4% 로 구성됩니다. 9.4% 급여 및 90.6% 보너스(회사 주식 및 옵션 포함). 는 $ 78.88M 가치에 해당하는 회사 주식의 1.41% 직접 소유합니다. 78.88M. 경영진과 이사회의 평균 재임 기간은 각각 5.5 년과 11.1 년입니다.
주요 정보
Waleed Hassanein
최고 경영자
US$6.8m
총 보상
| CEO 급여 비율 | 9.4% |
| CEO 임기 | 26.1yrs |
| CEO 소유권 | 1.4% |
| 경영진 평균 재임 기간 | 7.4yrs |
| 이사회 평균 재임 기간 | 11.1yrs |
최근 관리 업데이트
Recent updates
Returns Are Gaining Momentum At TransMedics Group (NASDAQ:TMDX)
Sep 18
TransMedics: Take Profits While The Valuation Is Sky High
Sep 18TransMedics: Wide Moat Player At A Lower Valuation Than Peers
Sep 10TransMedics Group, Inc.'s (NASDAQ:TMDX) P/S Is Still On The Mark Following 25% Share Price Bounce
Aug 28TransMedics: Heart And Lungs Will Drive The Next Leg Higher
Aug 19Analysts Just Made A Meaningful Upgrade To Their TransMedics Group, Inc. (NASDAQ:TMDX) Forecasts
Aug 06TransMedics Group: Providing Long-Term Detailed Forecast And Upgrading To Buy
Aug 04TransMedics Group, Inc. Just Recorded A 66% EPS Beat: Here's What Analysts Are Forecasting Next
Aug 02TransMedics Group Stock: Too Far, Too Fast
Jul 08TransMedics: NOP, Logistics And Transport Are Key Growth Drivers But Stock Is Pricey
Jun 17TransMedics Group (NASDAQ:TMDX) Might Have The Makings Of A Multi-Bagger
Jun 10TransMedics: Transportation Supporting Growth
May 21TransMedics Group: Looking At The Road Ahead After An Exceptional Q1 (Rating Downgrade)
May 06TransMedics Group, Inc. (NASDAQ:TMDX) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable
Apr 24TransMedics Group: Founder Led Company With Solid Potential
Apr 19Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 11TransMedics Group: Emerging Medical Device Market Leader With A Long Growth Runway
Mar 19TransMedics Group: Huge Opportunity In Organ Transplants
Mar 12TransMedics: A Very Expensive Growth Stock
Feb 07With TransMedics Group, Inc. (NASDAQ:TMDX) It Looks Like You'll Get What You Pay For
Jan 23Calculating The Fair Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Jan 02Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet?
Nov 05This Just In: Analysts Are Boosting Their TransMedics Group, Inc. (NASDAQ:TMDX) Outlook for This Year
Aug 06TransMedics Group (NASDAQ:TMDX) Has Debt But No Earnings; Should You Worry?
Aug 02TransMedics Group, Inc. (NASDAQ:TMDX) Not Lagging Industry On Growth Or Pricing
Jun 29Brokers Are Upgrading Their Views On TransMedics Group, Inc. (NASDAQ:TMDX) With These New Forecasts
May 06Is TransMedics Group (NASDAQ:TMDX) Using Too Much Debt?
Apr 27Estimating The Intrinsic Value Of TransMedics Group, Inc. (NASDAQ:TMDX)
Apr 09Is TransMedics Group (NASDAQ:TMDX) A Risky Investment?
Jan 16CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$3m |
| Mar 31 2024 | n/a | n/a | -US$10m |
| Dec 31 2023 | US$7m | US$634k | -US$25m |
| Sep 30 2023 | n/a | n/a | -US$36m |
| Jun 30 2023 | n/a | n/a | -US$18m |
| Mar 31 2023 | n/a | n/a | -US$28m |
| Dec 31 2022 | US$3m | US$575k | -US$36m |
| Sep 30 2022 | n/a | n/a | -US$42m |
| Jun 30 2022 | n/a | n/a | -US$48m |
| Mar 31 2022 | n/a | n/a | -US$47m |
| Dec 31 2021 | US$7m | US$535k | -US$44m |
| Sep 30 2021 | n/a | n/a | -US$38m |
| Jun 30 2021 | n/a | n/a | -US$30m |
| Mar 31 2021 | n/a | n/a | -US$28m |
| Dec 31 2020 | US$2m | US$534k | -US$29m |
| Sep 30 2020 | n/a | n/a | -US$32m |
| Jun 30 2020 | n/a | n/a | -US$35m |
| Mar 31 2020 | n/a | n/a | -US$36m |
| Dec 28 2019 | US$3m | US$449k | -US$34m |
| Sep 28 2019 | n/a | n/a | -US$32m |
| Jun 29 2019 | n/a | n/a | -US$29m |
| Mar 30 2019 | n/a | n/a | -US$26m |
| Dec 29 2018 | US$524k | US$384k | -US$24m |
| Sep 29 2018 | n/a | n/a | -US$21m |
| Jun 30 2018 | n/a | n/a | -US$20m |
| Mar 31 2018 | n/a | n/a | -US$20m |
| Dec 30 2017 | US$601k | US$351k | -US$21m |
보상 대 시장: Waleed 의 총 보상 ($USD 6.76M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 8.45M ).
보상과 수익: Waleed 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Waleed Hassanein (56 yo)
26.1yrs
테뉴어
US$6,758,070
보상
Dr. Waleed H. Hassanein, M.D. is the Founder of Transmedics Group, Inc. and has been its President, Chief Executive Officer and Director since August 1998. He Founded TransMedics, Inc. in August 1998 and h...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 26.1yrs | US$6.76m | 1.41% $ 74.7m | |
| CFO, Treasurer & Secretary | 9.5yrs | US$2.64m | 0.064% $ 3.4m | |
| Senior Vice President of Supply Chain & Operations | 1.7yrs | US$2.52m | 0.0097% $ 512.8k | |
| Senior VP | 1.2yrs | US$2.35m | 0.027% $ 1.4m | |
| Chief Commercial Officer | 18.7yrs | US$2.63m | 0.062% $ 3.3m | |
| Vice President of Global Regulatory Affairs | 5.3yrs | US$813.47k | 데이터 없음 |
7.4yrs
평균 재임 기간
56yo
평균 연령
경험이 풍부한 관리: TMDX 의 관리팀은 노련하고 경험 (평균 재직 기간 5.2 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Founder | 26.1yrs | US$6.76m | 1.41% $ 74.7m | |
| Independent Director | 21.7yrs | US$220.28k | 0.91% $ 48.4m | |
| Independent Director | 3.7yrs | US$238.62k | 0.0036% $ 190.1k | |
| Independent Chairman | 13.7yrs | US$262.32k | 0.52% $ 27.7m | |
| Member of Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 8.6yrs | US$232.26k | 0.0022% $ 116.3k | |
| Independent Director | 8.1yrs | US$237.74k | 0.0036% $ 190.1k |
11.1yrs
평균 재임 기간
70.5yo
평균 연령
경험이 풍부한 이사회: TMDX 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 10.9 년).